These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9309140)

  • 1. [HS1 and EMS1].
    He H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1448-53. PubMed ID: 9309140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortactin regulates cell migration through activation of N-WASP.
    Kowalski JR; Egile C; Gil S; Snapper SB; Li R; Thomas SM
    J Cell Sci; 2005 Jan; 118(Pt 1):79-87. PubMed ID: 15585574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation.
    He H; Watanabe T; Zhan X; Huang C; Schuuring E; Fukami K; Takenawa T; Kumar CC; Simpson RJ; Maruta H
    Mol Cell Biol; 1998 Jul; 18(7):3829-37. PubMed ID: 9632767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the EMS1 gene and its product, human Cortactin.
    Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
    Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein.
    Lin J; Liu J; Wang Y; Zhu J; Zhou K; Smith N; Zhan X
    Oncogene; 2005 Mar; 24(12):2059-66. PubMed ID: 15688017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-mediated cleavage of actin-binding and SH3-domain-containing proteins cortactin, HS1, and HIP-55 during apoptosis.
    Chen YR; Kori R; John B; Tan TH
    Biochem Biophys Res Commun; 2001 Nov; 288(4):981-9. PubMed ID: 11689006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Arp2/3 complex-mediated actin polymerization by cortactin.
    Uruno T; Liu J; Zhang P; Fan Yx ; Egile C; Li R; Mueller SC; Zhan X
    Nat Cell Biol; 2001 Mar; 3(3):259-66. PubMed ID: 11231575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.
    van Rossum AG; Schuuring-Scholtes E; van Buuren-van Seggelen V; Kluin PM; Schuuring E
    BMC Genomics; 2005 Feb; 6():15. PubMed ID: 15710041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.
    Patel AS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1998 Jun; 16(25):3227-32. PubMed ID: 9681820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional characterization of protein 4.1R and actin-binding sites in erythrocyte beta spectrin: regulation of the interactions by phosphatidylinositol-4,5-bisphosphate.
    An X; Debnath G; Guo X; Liu S; Lux SE; Baines A; Gratzer W; Mohandas N
    Biochemistry; 2005 Aug; 44(31):10681-8. PubMed ID: 16060676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
    Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure of an F-actin-binding "headpiece" motif from villin.
    Vardar D; Buckley DA; Frank BS; McKnight CJ
    J Mol Biol; 1999 Dec; 294(5):1299-310. PubMed ID: 10600386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into a single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking.
    Hoeflich KP; Tsukita S; Hicks L; Kay CM; Tsukita S; Ikura M
    Biochemistry; 2003 Oct; 42(40):11634-41. PubMed ID: 14529273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
    Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
    Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortactin regulates podosome formation: roles of the protein interaction domains.
    Webb BA; Eves R; Mak AS
    Exp Cell Res; 2006 Apr; 312(6):760-9. PubMed ID: 16434035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.